Astrazeneca

Jul 27, 2015 at 14:58 | Source: Reuters
Sanofi's rare diseases division Genzyme will pay AstraZeneca up to USD 300 million for global rights to Caprelsa, including an upfront payment of USD 165 million and milestone payments based on the drug's performance of up to USD 135 million, the companies said on Monday.
Jun 11, 2015 at 16:41 | Source: Moneycontrol.com
No sector was spared and all the major sectoral indices ended in the red. The midcaps fell in tandem with the bluechips as the index lost over 200 points.
Jun 11, 2015 at 15:09 | Source: PTI
The pharma company had received the approval of Drug Controller General of India in February.
Jun 11, 2015 at 13:27 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Tata Motors, Bank of Maharashtra, Nalco, DLF, AstraZeneca, Surana Solar, Asian Paints, HDIL and JSPL.
Jun 11, 2015 at 10:58 | Source: Moneycontrol.com
Investors continued to buy shares of AstraZeneca Pharma India on Thursday after the company launched FORXIGA (dapaglifozin), a treatment for Type 2 diabetes mellitus. The stock rallied 20 percent intraday amid high volumes.
Jun 11, 2015 at 09:45 | Source: Moneycontrol.com
AstraZeneca Pharma India today announced the launch of FORXIGA, a breakthrough treatment for Type 2 diabetes mellitus.
Jun 02, 2015 at 09:23 | Source: Moneycontrol.com
AstraZeneca Pharma India and Sun Pharmaceutical Industries today said they have entered into a distribution services agreement for AstraZenecas brand Axcer, a new brand of ticagrelor, in India.
Jun 02, 2015 at 08:46 | Source: Moneycontrol.com
Sun Pharmaceutical Industries and AstraZeneca Pharma India have entered into a distribution services agreement in India for AstraZenecas brand Axcer, a new brand of ticagrelor, a drug used for the treatment of acute coronary syndrome (ACS).
May 29, 2015 at 22:10 | Source: PTI
Dr Reddy's Laboratories senior vice president and head of India business Alok Sonig said the partnership would expand access to innovative medicines to vast number of diabetes patients in India.
May 28, 2015 at 13:27 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - Adani Enterprises, Gammon Infrastructure, Idea Cellular, Godrej Industries, Punjab National Bank, Tanla Solutions, Amtek Auto, Trident, EIL and Astrazeneca.
Messages on Astrazeneca »

babuji555

Platinum Member

1481 Followers

L&T Finance  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

8.57 PM Jul 7th 2014

livelovelau
gh

Platinum Member

597 Followers

Maha ShreeUmaid  

Right now promoters of Dic india ,fulford ,astrazeneca and ahlcon parent have got approved postal ballot resolution wherein thinly traded company UMS techno is starting rbb and Reil electronic is in the process to secure postal ballot approval.

1.31 PM Jul 7th 2014

AstraZeneca  

Shooting up! Good news in the cards. Buy, last chance before revised delisting price announced. - My target for AstraZeneca is Rs 1600 for the short term with a stoploss of Rs 1100

1.11 PM Jul 2nd 2014

babuji555

Platinum Member

1481 Followers

ITC  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

9.02 PM Jun 29th 2014

babuji555

Platinum Member

1481 Followers

ONGC  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

8.41 PM Jun 29th 2014

livelovelau
gh

Platinum Member

597 Followers

Essar Oil  

there will be a schedule soon wherein last date for voting and result date will be announced. in the history of d listing there has been only 2 cases where shareholders have rejected d listing at postal ballot or in other words one can say promoters failed to manage postal ballot of Astrazeneca

11.34 AM Jun 27th 2014

Ricoh India  

Traders cautious on delisting after Ricoh India bets turn sour Distinctly less agression in AstraZeneca and Essar Oil cases after earlier bet on Ricoh went sour; fear of stock price fall Sneha Padiyath & Samie Modak | Mumbai June 25, 2014 Last Updated at 22:49 IST on Business Standard

7.30 PM Jun 26th 2014

john_H

Silver Member

114 Followers

AstraZeneca  

Hold on. Astrazeneca will not be abke to fool the small investors and get away with delisting by manipulating the book building process. Sebi has its watchful eyes on it. .

6.28 PM Jun 25th 2014

Stock Tracker

Platinum Member

1435 Followers

AstraZeneca  

Will AstraZeneca Pharmaceuticals AB Sweden be able to delist its subsidiary Astrazeneca Pharma India from BSE and NSE?

5.47 PM Jun 25th 2014

livelovelau
gh

Platinum Member

597 Followers

Fulford  

TODAY ...postal ballot result of 2 mnc`s ASTRAZENECA and FULFORD !

11.02 AM Jun 20th 2014

News across the web »
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.